Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2019-06-25
2020-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
early denudation
Cumulus-oocyte complexes will be denudated in 30 min after oocyte retrieval
early denudation
COCs will be denudated in 30 min after oocyte retrieval
late denudation
Denudation will be done 2 hr after oocyte retrieval
late denudation
COCs will be denudated 2 hr after oocyte retrieval
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
early denudation
COCs will be denudated in 30 min after oocyte retrieval
late denudation
COCs will be denudated 2 hr after oocyte retrieval
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 5 or more oocytes collected
Exclusion Criteria
* Previous history of total fertilization failure or oocyte maturation arrest
* Male partner requiring surgical sperm retrieval (MESA or TESA).
20 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acıbadem Atunizade Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elif Esra Uyar
Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Acibadem Altunizade Hospitai
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Esra Uyar
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COCdenudation
Identifier Type: -
Identifier Source: org_study_id